Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
Novavax's updated JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3Novavax's JN.1 COVID-19 vaccine would be…
